FDA Approval is not possible without full clinical trials. EUA is possible but HGEN has not filed and who knows when that will happen. Second, have you read the analysis reports? If not, you should because their share price estimates are based on EUA approval and in most cases very aggressive revenue forecasts.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.